LabHealth
Peptide droplets cut colorectal tumor growth about 67% in mice
The two droplets silenced PD-1 in T cells and PD-L1 in tumor cells.
Written by AI1 source2 min
Loading…
Diagnostics, prosthetics, vaccines, genomics: the medicine that adds years to a life.
Medicine that wins years of life: AI-assisted screening examining millions of patients, next-generation vaccines, genomics moving from sequencing to treatment, prosthetics and implants restoring lost abilities. The section follows completed clinical trials, market authorisations, hospital roll-outs — the moment a technology stops being a paper and becomes care.
The numbers rule: cohorts, detection rates, avoided mortality, costs. We gladly cover the health systems deploying at scale — India, Brazil, Southeast Asia — because frugal technologies often prove themselves there before arriving anywhere else. Every article rests on the trial, authorisation or study behind it, and cites them.
The two droplets silenced PD-1 in T cells and PD-L1 in tumor cells.
ADAMTSL4 levels rose in mice and patients with colorectal or lung cancer who had cachexia.
UChicago researchers mapped how tumor cells organize into spatial groups across 262 solid tumors.
UCSF researchers used lab-made dendritic cells carrying tumor fragments from patients with leukemia and ovarian cancer.
Mass General Brigham researchers used aged tumor-bearing mice to screen for causes of T cell dysfunction.
The chip combines each patient's tumor cells with the surrounding blood-vessel barrier.
ULTRA creates 3D virtual histology of glioma tissue in about 30 minutes.
SHIFTERS uses focused ultrasound to make solid tumor cells briefly display CD19.